Other specified disorders of the nose and paranasal sinuses
Conditions
Interventions
Participants
This study included 12 patients aged between 50 and 79 years, with insufficiency of the nasal lateral wall, who were randomly divided into two groups: the implanted group (n=6) and the c
Sponsors
Pontifícia Universidade Católica do Paraná
Pontifícia Universidade Católica do Paraná
Eligibility
Age
50 Years to 79 Years
Inclusion criteria
Inclusion criteria: Patients aged between 50 and 79 years; with insufficiency of the nasal lateral wall confirmed through the positive Modified Cottle maneuver; with severe or extreme nasal obstruction in the evaluation by the NOSE Scale (Nasal Obstruction Symptom Evaluation Scale) (score = 55); impossibility or refusal to perform functional rhinoplasty; and lack of significant improvement after clinical treatment for at least four continuous months.
Exclusion criteria
Exclusion criteria: Smoking patients; with decompensated chronic rhinitis; with nasosinusal polyposis; with nasal granulomatous diseases; with any inflammatory or infectious diseases or conditions in the nasal or facial region; with a history of nasal implants or some type of nasal filling; with immunosuppressive disease; with healing disorders; with uncontrolled systemic diseases such as diabetes or heart disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease in nasal obstruction symptoms measured by the NOSE (Nose Obstruction Symptom Evaluation) and EVA (Visual Analog Scale) scales after 6 months of placement of a bioabsorbable nasal implant. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected. | — |
Countries
Brazil
Contacts
Public ContactAnderson Merkle
Outcome results
None listed